
Dianthus Therapeutics Inc
DNTHNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$91.52
Day High
$93.61
Day Low
$90.03
Prev. Close
$90.86
VolumeShares traded today.
1.15M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$5.08B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-22.49
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$96.50
52W LowLowest price over the past 52 weeks.
$16.64
50D MAAverage closing price over the last 50 trading days.
$86.89
200D MAAverage closing price over the last 200 trading days.
$53.33
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+3.8%1M
+11.4%6M
+111.0%YTD
+134.4%1Y
+434.8%About
Many fake or unproven medical products and methods claim to diagnose, prevent, or cure COVID-19. Fake medicines sold for COVID-19 may not contain the ingredients they claim to contain, and may even contain harmful ingredients. In March 2020, the World Health Organization (WHO) released a statement recommending against taking any medicines in an attempt to treat or cure COVID-19, although research on potential treatment was underway, including the Solidarity trial spearheaded by WHO. The WHO requested member countries to immediately notify them if any fake medicines or other falsified products were discovered. There are also many claims that existing products help against COVID-19, which are spread through rumors online rather than conventional advertising.
dianthustx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade DNTH
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.